{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:05:19Z","timestamp":1788829519649,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003761","name":"University Medical Centre Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.radonc.2025.111226","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:06:31Z","timestamp":1761260791000},"page":"111226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5130-3760","authenticated-orcid":false,"given":"S.M.L.","family":"Linden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.P.","family":"Philippens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3896-5234","authenticated-orcid":false,"given":"M.E.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2530-3038","authenticated-orcid":false,"given":"M.","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111226_b0005","doi-asserted-by":"crossref","unstructured":"Huang, G., et al., Laser surgery versus radiotherapy for T1a glottic carcinoma: a meta-analysis of oncologic outcomes. Vol. 137. 2017, England. 1204-1209.","DOI":"10.1080\/00016489.2017.1353706"},{"key":"10.1016\/j.radonc.2025.111226_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.oraloncology.2019.05.006","article-title":"Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach","volume":"94","author":"Di Credico","year":"2019","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/CEJ.0b013e3282b6fd40","article-title":"Alcohol and laryngeal cancer: an update","volume":"17","author":"La Vecchia","year":"2008","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2016.02.006","article-title":"Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent \u2013 A population based study from the DAHANCA group","volume":"118","author":"Lyhne","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2025.111226_b0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/coa.12790","article-title":"Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes","volume":"42","author":"Warner","year":"2017","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.radonc.2025.111226_b0030","unstructured":"Behandeling Tis\/T1 glottisch larynxcarcinoom 2023 [cited 2025 09-07]; Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/hoofd-halstumoren_sept_2023\/behandeling_bij_hht_2023\/larynxcarcinoom\/behandeling_tis_t1_glottisch_larynxcarcinoom.html."},{"issue":"11","key":"10.1016\/j.radonc.2025.111226_b0035","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00405-020-06012-9","article-title":"Moderate hypofractionation for early laryngeal cancer improves local control: a systematic review and meta-analysis","volume":"277","author":"Benson","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.radonc.2025.111226_b0040","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/annonc\/mdy036","article-title":"Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701)","volume":"29","author":"Kodaira","year":"2018","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2025.111226_b0045","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ijrobp.2023.06.251","article-title":"Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3)","volume":"117","author":"Kodaira","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111226_b0050","doi-asserted-by":"crossref","unstructured":"Sher, D.J., et al., Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer. Vol. 105. 2019, United States. 110-118.","DOI":"10.1016\/j.ijrobp.2019.03.010"},{"key":"10.1016\/j.radonc.2025.111226_b0055","doi-asserted-by":"crossref","unstructured":"Kang, B.H., et al., Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer. Vol. 105. 2019, United States. 104-109.","DOI":"10.1016\/j.ijrobp.2019.03.011"},{"issue":"6","key":"10.1016\/j.radonc.2025.111226_b0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0194599813503802","article-title":"Clinical assessment and treatment of the dysfunctional larynx after radiation","volume":"149","author":"Allen","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.radonc.2025.111226_b0075","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0194599820947702","article-title":"Risk Factors for Laryngectomy for Dysfunctional Larynx After Organ Preservation Protocols: A Case-Control Analysis","volume":"164","author":"Wu","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2025.111226_b0080","unstructured":"R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing. 2024; Available from: https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.radonc.2025.111226_b0085","unstructured":"Mathias Harrer, P.C., Toshi A. Furukawa, David D. Ebert., Subgroup analyses."},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.radonc.2025.111226_b0095","unstructured":"Wells, G.A., et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"10.1016\/j.radonc.2025.111226_b0100","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1148\/radiology.149.1.6611940","article-title":"Cancer of the glottis: prognostic factors in radiation therapy","volume":"149","author":"Mantravadi","year":"1983","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.radonc.2025.111226_b0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/02841868509136059","article-title":"A therapeutic approach to early vocal cord carcinoma","volume":"24","author":"Amornmarn","year":"1985","journal-title":"Acta Radiol Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0360-3016(98)90017-7","article-title":"Hypofractionation reduces the therapeutic ratio in early glottic carcinoma","volume":"15","author":"Harrison","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111226_b0120","doi-asserted-by":"crossref","unstructured":"Slevin, N.J., S. Vasanthan, and M. Dougal, Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. Vol. 25. 1993, United States. 23-8.","DOI":"10.1016\/0360-3016(93)90140-Q"},{"issue":"5","key":"10.1016\/j.radonc.2025.111226_b0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0360-3016(96)00431-2","article-title":"Radiation therapy in early carcinoma of the glottic larynx T1N0M0","volume":"36","author":"Medini","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-8140(97)01903-8","article-title":"Effect of arytenoid sparing during radiation therapy of early stage glottic carcinoma","volume":"43","author":"Allal","year":"1997","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0360-3016(96)00613-X","article-title":"Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment","volume":"38","author":"Burke","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0360-3016(97)00284-8","article-title":"Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma","volume":"39","author":"Le","year":"1997","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"4","key":"10.1016\/j.radonc.2025.111226_b0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0385-8146(97)00013-8","article-title":"The significance of arytenoid edema following radiotherapy of laryngeal carcinoma with respect to residual and recurrent tumour","volume":"24","author":"Ichimura","year":"1997","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-8140(97)00196-5","article-title":"Effect of tumor bulk on local control and survival of patients with T1 glottic cancer","volume":"47","author":"Reddy","year":"1998","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(98)00226-0","article-title":"The impact of treatment time and smoking on local control and complications in T1 glottic cancer","volume":"42","author":"van der Voet","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2025.111226_b0160","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cncr.11575","article-title":"Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients","volume":"98","author":"Franchin","year":"2003","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.radonc.2025.111226_b0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/000348940311201014","article-title":"Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis","volume":"112","author":"Chen","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"10.1016\/j.radonc.2025.111226_b0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/030089160409000310","article-title":"Hyperfractionated radiotherapy for T2N0 glottic carcinoma: a retrospective analysis at 10 years follow-up in a series of 60 consecutive patients","volume":"90","author":"Bignardi","year":"2004","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0175","first-page":"144","volume":"263","author":"Tateya","year":"2006","journal-title":"Head and Neck Surgery"},{"key":"10.1016\/j.radonc.2025.111226_b0180","doi-asserted-by":"crossref","unstructured":"Short, S., et al., TN\/TN glottic carcinoma: a comparison of two fractionation schedules. Vol. 50. 2006, Australia. 152-7.","DOI":"10.1111\/j.1440-1673.2006.01559.x"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/COC.0b013e3181a3194f","article-title":"Definitive radiotherapy for carcinoma in situ of the true vocal cords","volume":"33","author":"Sengupta","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2025.111226_b0190","first-page":"1383","article-title":"The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer","volume":"24","author":"Di Nicola","year":"2010","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyq153","article-title":"Radiotherapy for glottic T1N0 carcinoma with slight hypofractionation and standard overall treatment time: importance of overall treatment time","volume":"41","author":"Onimaru","year":"2011","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3342\/ceo.2012.5.2.94","article-title":"Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules","volume":"5","author":"Kim","year":"2012","journal-title":"Clinical and experimental otorhinolaryngology"},{"issue":"7","key":"10.1016\/j.radonc.2025.111226_b0205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hed.21860","article-title":"High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors","volume":"34","author":"Gultekin","year":"2012","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.radonc.2025.111226_b0210","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12094-013-1025-1","article-title":"Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience","volume":"15","author":"Cacicedo","year":"2013","journal-title":"Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0215","first-page":"125","volume":"271","author":"Al-Mamgani","year":"2014","journal-title":"Head and Neck Surgery"},{"issue":"5","key":"10.1016\/j.radonc.2025.111226_b0220","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2014.04.041","article-title":"Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)","volume":"89","author":"Trotti","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2025.111226_b0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hed.23641","article-title":"Accelerated radiotherapy for T1 to T2 glottic cancer","volume":"37","author":"Motegi","year":"2015","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13014-017-0915-8","article-title":"Conventional fractionation should not be the standard of care for T2 glottic cancer","volume":"12","author":"Dixon","year":"2017","journal-title":"Radiation oncology (London, England)"},{"key":"10.1016\/j.radonc.2025.111226_b0235","article-title":"Three-week hypofractionated radiotherapy in early glottic cancer\u2014a single institution retrospective study","volume":"16","author":"Sudha","year":"2022","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.radonc.2025.111226_b0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1748-717X-7-193","article-title":"Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience","volume":"7","author":"Khan","year":"2012","journal-title":"Radiation oncology (London, England)"},{"issue":"2","key":"10.1016\/j.radonc.2025.111226_b0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2478\/raon-2013-0020","article-title":"Evaluation of acute\/late toxicity and local recurrence in t1-t2 glottic carcinoma treated with accelerated hypofractionated 3d-conformal external beam radiotherapy (3d-crt)","volume":"47","author":"Kouloulias","year":"2013","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2013.09.016","article-title":"A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study","volume":"110","author":"Moon","year":"2014","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"7","key":"10.1016\/j.radonc.2025.111226_b0255","first-page":"4155","article-title":"Exclusive Radiotherapy for Early-stage Glottic Cancer: A Single-institution Retrospective Analysis with a Focus on Voice Quality","volume":"35","author":"Potenza","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2025.111226_b0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13014-015-0505-6","article-title":"Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions","volume":"10","author":"Ermi\u015f","year":"2015","journal-title":"Radiation oncology (London, England)"},{"key":"10.1016\/j.radonc.2025.111226_b0265","unstructured":"Itoh, Y., et al., A multicenter survey of stage T1 glottic cancer treated with radiotherapy delivered in 2.25-Gy fractions in clinical practice: An initial 5-year analysis. Nagoya journal of medical science, 2016. 78(4): p. 399-406 DOI:10.18999\/nagjms.78.4.399."},{"issue":"3","key":"10.1016\/j.radonc.2025.111226_b0270","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4103\/jcrt.JCRT_692_17","article-title":"Patterns of failure for early-stage glottic carcinoma: 10 years' experience in conformal radiotherapy era","volume":"15","author":"Sert","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2025.111226_b0275","doi-asserted-by":"crossref","unstructured":"Thariat, J., et al., Conservative treatment of early glottic carcinomas with exclusive radiotherapy. Vol. 8. 2004, France. 288-96.","DOI":"10.1016\/S1278-3218(04)00088-5"},{"issue":"4","key":"10.1016\/j.radonc.2025.111226_b0280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.canrad.2017.01.015","article-title":"A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiation","volume":"21","author":"Robert","year":"2017","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijrobp.2024.09.051","article-title":"Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer","volume":"121","author":"Sanguineti","year":"2025","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"5","key":"10.1016\/j.radonc.2025.111226_b0290","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/hed.26052","article-title":"Feasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer","volume":"42","author":"Chung","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.111226_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105782","article-title":"Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile","volume":"127","author":"Tans","year":"2022","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2025.111226_b0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijrobp.2024.07.2147","article-title":"Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR Trial","volume":"121","author":"Sher","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.radonc.2025.111226_b0305","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s00405-023-07904-2","article-title":"Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma","volume":"280","author":"de Ridder","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"9","key":"10.1016\/j.radonc.2025.111226_b0310","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/hed.28139","article-title":"Ultra-Hypofractionated Radiotherapy for Early-Stage Glottic Cancer: Real-World Data From a Single Center","volume":"47","author":"Gundog","year":"2025","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.radonc.2025.111226_b0315","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/hed.27101","article-title":"Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society\/TROD-01-007","volume":"44","author":"Bicakci","year":"2022","journal-title":"Head Neck"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:30:55Z","timestamp":1786537855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025052302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"alternative-id":["S0167814025052302"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111226","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111226"}}